1. Home
  2. NRIX vs HLIO Comparison

NRIX vs HLIO Comparison

Compare NRIX & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$24.94

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Helios Technologies Inc.

HLIO

Helios Technologies Inc.

HOLD

Current Price

$82.23

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRIX
HLIO
Founded
2009
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
NRIX
HLIO
Price
$24.94
$82.23
Analyst Decision
Strong Buy
Buy
Analyst Count
12
6
Target Price
$30.50
$66.17
AVG Volume (30 Days)
1.1M
258.5K
Earning Date
04-08-2026
05-11-2026
Dividend Yield
N/A
0.72%
EPS Growth
N/A
23.93
EPS
N/A
0.59
Revenue
$76,987,000.00
$200,727,000.00
Revenue This Year
N/A
$3.67
Revenue Next Year
$48.05
$5.00
P/E Ratio
N/A
$138.07
Revenue Growth
99.31
N/A
52 Week Low
$8.20
$47.05
52 Week High
$25.09
$95.05

Technical Indicators

Market Signals
Indicator
NRIX
HLIO
Relative Strength Index (RSI) 66.01 54.22
Support Level $14.63 $78.81
Resistance Level $24.98 $83.99
Average True Range (ATR) 1.09 2.59
MACD -0.10 0.32
Stochastic Oscillator 79.66 79.95

Price Performance

Historical Comparison
NRIX
HLIO

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

Share on Social Networks: